Asztma: vizsgálatok itt: Olaszország
25 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
- Where
- Catania, Naples, Rome
- Életkor
- 6 év to 11 év
- People
- 200 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05562466 · EU 2022-501899-26-00 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- Where
- Genova, Pavia, Roma
- Életkor
- 5 év to 11 év
- People
- 231 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06023589 - 3. fázisTaking peopleRoll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
- Where
- Roma
- Életkor
- 6 év and over
- People
- 230 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07444567 - 2. fázisTaking peopleA Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Where
- Monserrato, Orbassano, Reggio Emilia, Rozzano MI, Salerno, Siena, Turin
- Életkor
- 18 év to 75 év
- People
- 252 worldwide
- Run by
- Pfizer
See details and how to joinNCT06977581 · EU 2024-517866-40-00 - 4. fázisTaking peopleA Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
- Where
- Brescia, Catanzaro, Genoa, Milan, Montebelluna, Palermo, Rozzano
- Életkor
- 6 év and over
- People
- 2500 worldwide
- Run by
- Sanofi
See details and how to joinNCT07556159 · EU 2025-524916-13-00 - 3. fázisTaking peopleA Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
- Where
- Brescia, Pavia, Reggio Emilia, Sassari, Trieste
- Életkor
- 12 év to 80 év
- People
- 786 worldwide
- Run by
- Generate Biomedicines
See details and how to joinNCT07359846 - 2. fázisTaking peopleDose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Where
- Catania, Foggia, Genoa, Rome
- Életkor
- 18 év to 75 év
- People
- 540 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06932263 · EU 2024-519116-14-00 - No phaseTaking peopleAsthma and Primary Arterial Hypertension: an Inflammatory Link?
- Where
- Tradate
- Életkor
- 18 év to 85 év
- People
- 74
- Run by
- Istituti Clinici Scientifici Maugeri SpA
See details and how to joinNCT07903805 - 2. fázisTaking peopleA Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
- Where
- Rome
- Életkor
- 18 év to 75 év
- People
- 264 worldwide
- Run by
- Kymera Therapeutics, Inc.
See details and how to joinNCT07323654 - 3. fázisNot yet taking people in OlaszországSafety and Efficacy Comparison Between CHF5993 100/6 12.5µg pMDI to Seretide Evohaler 125/25µg pMDI in Adolescent Subjects With Asthma
- Where
- Brescia, Brindisi, Genoa, Messina, Milan, Naples, Napoli, Parma, Pisa, Rome, Rozzano
- Életkor
- 12 év to 17 év
- People
- 700 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07858123 · EU 2024-514248-95-00 - 2. fázisNot yet taking people in OlaszországA Long-term Study of KT-621 Administered Orally to Participants with Asthma Previously Enrolled in a KT-621 Asthma Study
- Where
- Bari, Genoa, Milan, Naples, Rome
- Életkor
- 18 év and over
- People
- 77 worldwide
- Run by
- Kymera Therapeutics Inc.
See details and how to join2026-526241-98-00 · EU 2026-526241-98-00 - 2. fázisCsak meghívásosLong-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
- Where
- Ancona, Genoa, Modena, Monserrato, Palermo, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Sanofi
See details and how to joinNCT06609239 · EU 2025-522896-27-00 - No phaseTaking peopleA Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy
- Where
- Bari, Bergamo, Bologna, Brescia, Catania, Catanzaro, Florence, Foggia, Messina, Milan, Modena, Naples, Padova, Palermo, Pavia, Roma, Salerno, Sassari, Siena, Teramo, Torino, Treviso, Varese, Verona
- Életkor
- 18 év and over
- People
- 335
- Run by
- AstraZeneca
See details and how to joinNCT07214753 - 2. fázisTaking peopleA Study of KT-621 Administered Orally to Adult Participants with Moderate to Severe Eosinophilic Asthma
- Where
- Bari, Genoa, Milan, Naples, Rome
- Életkor
- 18 év and over
- People
- 121 worldwide
- Run by
- Kymera Therapeutics Inc.
See details and how to join2025-523180-38-00 · EU 2025-523180-38-00 - 3. fázisTaking peopleROSY-F: Roll-over Study for Participants Who Have Completed a Previous Clinical Study with Benralizumab (Fasenra) and Benefit from Continued Treatment
- Where
- Rome
- People
- 94 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-523307-29-00 · EU 2025-523307-29-00 - 3. fázisTaking peopleA Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
- Where
- Ancona, Bari, Brescia, Catania, Catanzaro, Florence, Genoa, Monserrato, Rome, Rozzano, Tradate, Verona
- Életkor
- 12 év and over
- People
- 456 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07456033 · EU 2025-524463-20-00 - 3. fázisCsak meghívásosEfficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
- Where
- Milan, Naples, Padova, Pavia, Rome
- Életkor
- 2 év to 5 év
- People
- 90 worldwide
- Run by
- Sanofi
See details and how to joinNCT06191315 · EU 2023-504331-41-00 - 3. fázisTaking peopleA Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma (SOLAIRIA-1)
- Where
- Brescia, Orbassano, Pavia, Reggio Emilia, Rome, Rozzano, Sassari, Taranto, Trieste
- People
- 80 worldwide
- Run by
- Generate Biomedicines Inc.
See details and how to join2025-524040-35-00 · EU 2025-524040-35-00 - 4. fázisTaking peopleBETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])
- Where
- Battipaglia, Ferrara, Florence, Foggia, Genoa, Rome
- Életkor
- 18 év and over
- People
- 644 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07666490 · EU 2025-524289-56-00 - 3. fázisTaking peopleDepemokimab Asthma Imaging and Bronchoscopy Sub-Study
- Where
- Catania, Florence, Genoa, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06979323 · EU 2024-519976-19-00 - No phaseTaking peopleSevere Asthma Network Italy
- Where
- Rozzano
- Életkor
- 13 év and over
- People
- 5000
- Run by
- Società Italiana di Allergologia, Asma e Immunologia Clinica
See details and how to joinNCT06625216 - No phaseTaking peopleRole of "Asthma School" in Disease Management
- Where
- Tradate
- Életkor
- 18 év to 85 év
- People
- 92
- Run by
- Istituti Clinici Scientifici Maugeri SpA
See details and how to joinNCT04442646 - No phaseTaking peopleASMact: Study on Management of Bronchial Asthma
- Where
- Ferrara, Florence
- Életkor
- 6 év to 17 év
- People
- 500
- Run by
- Meyer Children's Hospital IRCCS
See details and how to joinNCT07412769 - 4. fázisCsak meghívásosBeyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA
- Where
- Cagliari
- Életkor
- 18 év and over
- People
- 90
- Run by
- Azienda Ospedaliero Universitaria di Cagliari
See details and how to joinNCT07343661 - No phaseTaking peopleMANI Real-life Perspective Observatory
- Where
- Genova
- Életkor
- 18 év to 99 év
- People
- 20 000
- Run by
- Societa Italiana di Pneumologia
See details and how to joinNCT04796844